Epilepsy Foundation
Giving Philosophy
The Foundation funds research that may not be currently fundable by traditional agencies like NHMRC due to preliminary nature, with emphasis on early career researchers and rare genetic epilepsies. They employ a unique peer review process combining scientific assessment with input from people living with epilepsy and carers to ensure research has real-world impact. Priority is given to high-quality research that will fundamentally benefit people living with epilepsy, with equal consideration for rare and common epilepsy conditions.
Tips for Applicants
Applications undergo rigorous peer review by external scientific reviewers AND a committee of people living with epilepsy/carers, so clearly articulate both scientific merit and real-world impact. The Foundation uses ARC-style grading (A-E) with only top 10% rated 'Outstanding'. Emphasize relative to opportunity (ROPE) factors including career disruptions, available resources, and for Indigenous applicants, community obligations. Projects must demonstrate feasibility, innovation, and transformative potential. Chief Investigators can hold maximum 5 concurrent AERF grants. Declare all conflicts of interest upfront or risk rejection. Consider positioning research as preliminary work that may not yet qualify for NHMRC/ARC funding. Budget justifications must be thorough.
Programs & Opportunities (3)
This grant, in collaboration with Syngap Research Fund Australia, sought Expressions of Interest (EOI) from investigators for SYNGAP-1 research, focusing on novel therapeutic approaches or clinical trial readiness projects for SYNGAP-1.
Grants for medical and psycho-social research into epilepsy including pre-clinical, translational, clinical and social/community research. Must be for organisations with DGR Item 1 and Tax Concession Charity status.
This fund supports innovative and high-quality research aimed at curing epilepsy or reducing its impact on people's lives, and finding new and improved treatments. It supports researchers, universities, research institutes, and hospitals, with applications open to organisations holding Deductible Gift Recipient (DGR) Item 1 and Tax Concession Charity (TCC) status.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $11.1M | $11.1M | $17.9M | $62K |
| 2022 | $9.9M | $10.0M | $18.6M | $-103,112 |
| 2021 | $8.7M | $6.9M | $18.7M | $1.8M |
| 2020 | $6.5M | $6.3M | $14.6M | $178K |
| 2019 | $5.0M | $4.7M | $8.3M | $299K |
| 2018 | $4.1M | $4.0M | $6.1M | $134K |
| 2017 | $4.2M | $4.2M | $5.9M | $24K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-75967571784
- ABN
- 75967571784
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- ANDREW HARRINGTON MACMILLANboard member
- Catherine Marshallboard member
- Christine Walkerboard member
- Dennis Clarkboard member
- LYNNE GALLUCCIboard member
- Mark Cookboard member
- Rosanne Bellboard member
- JOSEPH AZOULAYchair
Financials
- Revenue
- $11.1M
- Assets
- $17.9M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 23
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3126
- Locality
- CAMBERWELL EAST
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Boroondara
- SA2 Region
- Surrey Hills (West) - Canterbury
- Entities in Area
- 123
Disability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.